Concepedia

Taxane-based Combinations

Taxane-Based Combinations is a combination chemotherapy regimen in which a taxane-class microtubule inhibitor serves as the foundational cytotoxic agent, distinguished by its mechanism of promoting tubulin polymerization and stabilizing microtubules to induce mitotic arrest in cancer cells.

137

Publications

5.8K

Citations

1.1K

Authors

433

Institutions

Publications per year

2017–2026

21

Variants

Taxane-based Combination Chemotherapy

Parents

Publications

137

Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.

Noriaki Sawada, T Ishikawa, Yu Fukase et al. · PubMed · 1998 · 425 citations

, , +13

Measuring the side effects of taxane therapy in oncology

David Cella, Amy H. Peterman, Stacie Hudgens et al. · Cancer · 2003 · 288 citations

, , +13

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

Miguel Martín, Monserrat Muñoz, A. Balil et al. · The Lancet Oncology · 2007 · 186 citations

, , +16

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

PierFranco Conte, Antonio Frassoldati, Giancarlo Bisagni et al. · Annals of Oncology · 2018 · 155 citations · Full text

, , +17

Taxol

William J. Slichenmyer, Daniel D Von Hoff · Anti-Cancer Drugs · 1991 · 154 citations

, , +16

1–5 of 137

Authors

1.1K

  1. JH
    Jens Huober

    German Breast group, Germany

    3 publications · 156 citations

    3

    h-index

  2. HP
    Haralabos P. Kalofonos

    University of Patras, Greece

    3 publications · 159 citations

    3

    h-index

  3. VG
    Valentina Guarneri

    Istituto Oncologico Veneto, Italy

    3 publications · 194 citations

    3

    h-index

  4. EC
    Eva Carrasco

    GEICAM – Spanish Breast Cancer Group, Spain

    3 publications · 318 citations

    3

    h-index

  5. MM
    Miguel Martín

    Hospital General Universitario Gregorio Marañón, Spain

    3 publications · 218 citations

    3

    h-index

1–5 of 1.1K

Institutions

433

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    8 h-index

    41 publications

    1.2K citations

  2. Dana-Farber Cancer Institute

    Boston, United States

    6 h-index

    30 publications

    889 citations

  3. National Cancer Institute

    Bethesda, United States

    5 h-index

    13 publications

    503 citations

  4. Istituti di Ricovero e Cura a Carattere Scientifico

    Rome, Italy

    4 h-index

    13 publications

    914 citations

  5. Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

    Meldola, Italy

    4 h-index

    4 publications

    241 citations

  6. University of Michigan

    Ann Arbor, United States

    4 h-index

    16 publications

    300 citations

  7. Bristol-Myers Squibb (United States)

    New York, United States

    4 h-index

    6 publications

    335 citations

  8. National and Kapodistrian University of Athens

    Athens, Greece

    4 h-index

    7 publications

    427 citations

1–8 of 433

Venues

  1. PubMed

    Repository · 20 publications · 898 citations

    13

    h-index

  2. Journal of Clinical Oncology

    16 publications · 453 citations

    12

    h-index

  3. Anti-Cancer Drugs

    5 publications · 331 citations

    5

    h-index

  4. Clinical Cancer Research

    5 publications · 269 citations

    5

    h-index

  5. Annals of Oncology

    5 publications · 312 citations

    5

    h-index

1–5